Ironwood Pharmaceuticals Correlations
IRWD Stock | USD 3.34 0.18 5.11% |
The current 90-days correlation between Ironwood Pharmaceuticals and Amphastar P is 0.48 (i.e., Very weak diversification). The correlation of Ironwood Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Ironwood Pharmaceuticals Correlation With Market
Very weak diversification
The correlation between Ironwood Pharmaceuticals and DJI is 0.5 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ironwood Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Ironwood |
Moving together with Ironwood Stock
0.68 | VRAX | Virax Biolabs Group | PairCorr |
0.61 | REVB | Revelation Biosciences | PairCorr |
0.61 | STOK | Stoke Therapeutics | PairCorr |
0.66 | BDRX | Biodexa Pharmaceticals Upward Rally | PairCorr |
0.74 | CYTK | Cytokinetics | PairCorr |
Moving against Ironwood Stock
0.46 | VRDN | Viridian Therapeutics | PairCorr |
0.4 | EWTX | Edgewise Therapeutics | PairCorr |
0.34 | BMEA | Biomea Fusion | PairCorr |
0.33 | PRAX | Praxis Precision Med | PairCorr |
0.66 | T | ATT Inc Aggressive Push | PairCorr |
0.59 | PTAIF | PT Astra International | PairCorr |
0.54 | HD | Home Depot | PairCorr |
0.53 | WMT | Walmart Aggressive Push | PairCorr |
0.49 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
0.44 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
0.42 | DIS | Walt Disney Aggressive Push | PairCorr |
0.41 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Ironwood Stock performing well and Ironwood Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ironwood Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
NBIX | 1.50 | (0.37) | 0.00 | (0.19) | 0.00 | 3.10 | 19.99 | |||
AMPH | 1.58 | (0.15) | 0.00 | (0.04) | 0.00 | 3.37 | 17.30 | |||
COLL | 1.88 | (0.36) | 0.00 | (0.24) | 0.00 | 3.59 | 12.29 | |||
ANIP | 1.83 | (0.25) | 0.00 | (0.11) | 0.00 | 3.70 | 10.82 | |||
ALKS | 1.70 | (0.14) | (0.04) | 0.00 | 2.11 | 4.14 | 9.74 | |||
ITCI | 1.36 | 0.10 | 0.05 | 0.20 | 1.45 | 3.04 | 16.17 | |||
DCPH | 1.66 | (0.22) | 0.00 | (0.90) | 0.00 | 3.27 | 9.66 | |||
PCRX | 1.88 | 0.23 | 0.11 | 0.29 | 1.93 | 3.96 | 10.38 | |||
AVDL | 2.30 | (0.61) | 0.00 | (0.60) | 0.00 | 2.90 | 39.15 | |||
EGRX | 3.94 | (1.28) | 0.00 | (1.22) | 0.00 | 9.24 | 53.71 |
Ironwood Pharmaceuticals Corporate Management
Thomas McCourt | Chief Commercial Officer and Sr. VP of Marketing and Sales | Profile | |
Jana Noeldeke | Basel Leader | Profile | |
Ronald Silver | Corporate Officer | Profile | |
Marcel Moulaison | Vice Operations | Profile | |
Beth Calitri | Head Relations | Profile | |
Sravan Emany | Principal VP | Profile |